Selected research
Market Analysis & Forecast
Global Obstetric Risk Assessment Solutions Market Analysis and Forecast 2026-2032
Market perspective
The global Obstetric Risk Assessment Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Obstetric Risk Assessment Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Obstetric Risk Assessment Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Obstetric Risk Assessment Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Obstetric Risk Assessment Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Obstetric Risk Assessment Solutions include Johns Hopkins University, Lightbeam Health Solutions, Dynamic Healthcare Systems, Evolent Health, GE Healthcare, Philips Healthcare, PerkinElmer, Fujifilm Healthcare and Canon Medical Systems, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Obstetric Risk Assessment Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Obstetric Risk Assessment Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Obstetric Risk Assessment Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Obstetric Risk Assessment Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Obstetric Risk Assessment Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Obstetric Risk Assessment Solutions revenue, projected growth trends, production technology, application and end-user industry.
Obstetric Risk Assessment Solutions Segment by Company
Johns Hopkins University
Lightbeam Health Solutions
Dynamic Healthcare Systems
Evolent Health
GE Healthcare
Philips Healthcare
PerkinElmer
Fujifilm Healthcare
Canon Medical Systems
Nihon Kohden
Jumper Medical
Cerner Corporation
Health Catalyst
HBI Solutions
Obstetric Risk Assessment Solutions Segment by Type
Screening Assessment
Diagnostic Assessment
Dynamic Monitoring Assessment
Others
Obstetric Risk Assessment Solutions Segment by Application
Public Hospital
Private Hospital
Obstetric Risk Assessment Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obstetric Risk Assessment Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Obstetric Risk Assessment Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obstetric Risk Assessment Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Obstetric Risk Assessment Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Obstetric Risk Assessment Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Obstetric Risk Assessment Solutions revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Screening Assessment
- Diagnostic Assessment
- Dynamic Monitoring Assessment
- Others
Applications
- Public Hospital
- Private Hospital
Companies covered
- Johns Hopkins University
- Lightbeam Health Solutions
- Dynamic Healthcare Systems
- Evolent Health
- GE Healthcare
- Philips Healthcare
- PerkinElmer
- Fujifilm Healthcare
- Canon Medical Systems
- Nihon Kohden
- Jumper Medical
- Cerner Corporation
- Health Catalyst
- HBI Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Obstetric Risk Assessment Solutions Market by Type
- 1.2.1 Global Obstetric Risk Assessment Solutions Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Screening Assessment
- 1.2.3 Diagnostic Assessment
- 1.2.4 Dynamic Monitoring Assessment
- 1.2.5 Others
- 1.3 Obstetric Risk Assessment Solutions Market by Application
- 1.3.1 Global Obstetric Risk Assessment Solutions Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Public Hospital
- 1.3.3 Private Hospital
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Obstetric Risk Assessment Solutions Market Dynamics
- 2.1 Obstetric Risk Assessment Solutions Industry Trends
- 2.2 Obstetric Risk Assessment Solutions Industry Drivers
- 2.3 Obstetric Risk Assessment Solutions Industry Opportunities and Challenges
- 2.4 Obstetric Risk Assessment Solutions Industry Restraints
3 Global Growth Perspective
- 3.1 Global Obstetric Risk Assessment Solutions Market Perspective (2021-2032)
- 3.2 Global Obstetric Risk Assessment Solutions Growth Trends by Region
- 3.2.1 Global Obstetric Risk Assessment Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Obstetric Risk Assessment Solutions Market Size by Region (2021-2026)
- 3.2.3 Global Obstetric Risk Assessment Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Obstetric Risk Assessment Solutions Revenue by Players
- 4.1.1 Global Obstetric Risk Assessment Solutions Revenue by Players (2021-2026)
- 4.1.2 Global Obstetric Risk Assessment Solutions Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Obstetric Risk Assessment Solutions Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Obstetric Risk Assessment Solutions Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Obstetric Risk Assessment Solutions Key Players Headquarters & Area Served
- 4.4 Global Obstetric Risk Assessment Solutions Players, Product Type & Application
- 4.5 Global Obstetric Risk Assessment Solutions Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Obstetric Risk Assessment Solutions Market CR5 and HHI
- 4.6.3 2025 Obstetric Risk Assessment Solutions Tier 1, Tier 2, and Tier 3
5 Obstetric Risk Assessment Solutions Market Size by Type
- 5.1 Global Obstetric Risk Assessment Solutions Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 5.3 Global Obstetric Risk Assessment Solutions Revenue Market Share by Type (2021-2032)
6 Obstetric Risk Assessment Solutions Market Size by Application
- 6.1 Global Obstetric Risk Assessment Solutions Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 6.3 Global Obstetric Risk Assessment Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Johns Hopkins University
- 7.1.1 Johns Hopkins University Company Information
- 7.1.2 Johns Hopkins University Business Overview
- 7.1.3 Johns Hopkins University Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.1.4 Johns Hopkins University Obstetric Risk Assessment Solutions Product Portfolio
- 7.1.5 Johns Hopkins University Recent Developments
- 7.2 Lightbeam Health Solutions
- 7.2.1 Lightbeam Health Solutions Company Information
- 7.2.2 Lightbeam Health Solutions Business Overview
- 7.2.3 Lightbeam Health Solutions Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.2.4 Lightbeam Health Solutions Obstetric Risk Assessment Solutions Product Portfolio
- 7.2.5 Lightbeam Health Solutions Recent Developments
- 7.3 Dynamic Healthcare Systems
- 7.3.1 Dynamic Healthcare Systems Company Information
- 7.3.2 Dynamic Healthcare Systems Business Overview
- 7.3.3 Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.3.4 Dynamic Healthcare Systems Obstetric Risk Assessment Solutions Product Portfolio
- 7.3.5 Dynamic Healthcare Systems Recent Developments
- 7.4 Evolent Health
- 7.4.1 Evolent Health Company Information
- 7.4.2 Evolent Health Business Overview
- 7.4.3 Evolent Health Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.4.4 Evolent Health Obstetric Risk Assessment Solutions Product Portfolio
- 7.4.5 Evolent Health Recent Developments
- 7.5 GE Healthcare
- 7.5.1 GE Healthcare Company Information
- 7.5.2 GE Healthcare Business Overview
- 7.5.3 GE Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.5.4 GE Healthcare Obstetric Risk Assessment Solutions Product Portfolio
- 7.5.5 GE Healthcare Recent Developments
- 7.6 Philips Healthcare
- 7.6.1 Philips Healthcare Company Information
- 7.6.2 Philips Healthcare Business Overview
- 7.6.3 Philips Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.6.4 Philips Healthcare Obstetric Risk Assessment Solutions Product Portfolio
- 7.6.5 Philips Healthcare Recent Developments
- 7.7 PerkinElmer
- 7.7.1 PerkinElmer Company Information
- 7.7.2 PerkinElmer Business Overview
- 7.7.3 PerkinElmer Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.7.4 PerkinElmer Obstetric Risk Assessment Solutions Product Portfolio
- 7.7.5 PerkinElmer Recent Developments
- 7.8 Fujifilm Healthcare
- 7.8.1 Fujifilm Healthcare Company Information
- 7.8.2 Fujifilm Healthcare Business Overview
- 7.8.3 Fujifilm Healthcare Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.8.4 Fujifilm Healthcare Obstetric Risk Assessment Solutions Product Portfolio
- 7.8.5 Fujifilm Healthcare Recent Developments
- 7.9 Canon Medical Systems
- 7.9.1 Canon Medical Systems Company Information
- 7.9.2 Canon Medical Systems Business Overview
- 7.9.3 Canon Medical Systems Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.9.4 Canon Medical Systems Obstetric Risk Assessment Solutions Product Portfolio
- 7.9.5 Canon Medical Systems Recent Developments
- 7.10 Nihon Kohden
- 7.10.1 Nihon Kohden Company Information
- 7.10.2 Nihon Kohden Business Overview
- 7.10.3 Nihon Kohden Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.10.4 Nihon Kohden Obstetric Risk Assessment Solutions Product Portfolio
- 7.10.5 Nihon Kohden Recent Developments
- 7.11 Jumper Medical
- 7.11.1 Jumper Medical Company Information
- 7.11.2 Jumper Medical Business Overview
- 7.11.3 Jumper Medical Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.11.4 Jumper Medical Obstetric Risk Assessment Solutions Product Portfolio
- 7.11.5 Jumper Medical Recent Developments
- 7.12 Cerner Corporation
- 7.12.1 Cerner Corporation Company Information
- 7.12.2 Cerner Corporation Business Overview
- 7.12.3 Cerner Corporation Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.12.4 Cerner Corporation Obstetric Risk Assessment Solutions Product Portfolio
- 7.12.5 Cerner Corporation Recent Developments
- 7.13 Health Catalyst
- 7.13.1 Health Catalyst Company Information
- 7.13.2 Health Catalyst Business Overview
- 7.13.3 Health Catalyst Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.13.4 Health Catalyst Obstetric Risk Assessment Solutions Product Portfolio
- 7.13.5 Health Catalyst Recent Developments
- 7.14 HBI Solutions
- 7.14.1 HBI Solutions Company Information
- 7.14.2 HBI Solutions Business Overview
- 7.14.3 HBI Solutions Obstetric Risk Assessment Solutions Revenue and Gross Margin (2021-2026)
- 7.14.4 HBI Solutions Obstetric Risk Assessment Solutions Product Portfolio
- 7.14.5 HBI Solutions Recent Developments
8 North America
- 8.1 North America Obstetric Risk Assessment Solutions Revenue (2021-2032)
- 8.2 North America Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 8.2.1 North America Obstetric Risk Assessment Solutions Revenue by Type (2021-2026)
- 8.2.2 North America Obstetric Risk Assessment Solutions Revenue by Type (2027-2032)
- 8.3 North America Obstetric Risk Assessment Solutions Revenue Share by Type (2021-2032)
- 8.4 North America Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 8.4.1 North America Obstetric Risk Assessment Solutions Revenue by Application (2021-2026)
- 8.4.2 North America Obstetric Risk Assessment Solutions Revenue by Application (2027-2032)
- 8.5 North America Obstetric Risk Assessment Solutions Revenue Share by Application (2021-2032)
- 8.6 North America Obstetric Risk Assessment Solutions Revenue by Country
- 8.6.1 North America Obstetric Risk Assessment Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Obstetric Risk Assessment Solutions Revenue by Country (2021-2026)
- 8.6.3 North America Obstetric Risk Assessment Solutions Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Obstetric Risk Assessment Solutions Revenue (2021-2032)
- 9.2 Europe Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 9.2.1 Europe Obstetric Risk Assessment Solutions Revenue by Type (2021-2026)
- 9.2.2 Europe Obstetric Risk Assessment Solutions Revenue by Type (2027-2032)
- 9.3 Europe Obstetric Risk Assessment Solutions Revenue Share by Type (2021-2032)
- 9.4 Europe Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 9.4.1 Europe Obstetric Risk Assessment Solutions Revenue by Application (2021-2026)
- 9.4.2 Europe Obstetric Risk Assessment Solutions Revenue by Application (2027-2032)
- 9.5 Europe Obstetric Risk Assessment Solutions Revenue Share by Application (2021-2032)
- 9.6 Europe Obstetric Risk Assessment Solutions Revenue by Country
- 9.6.1 Europe Obstetric Risk Assessment Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Obstetric Risk Assessment Solutions Revenue by Country (2021-2026)
- 9.6.3 Europe Obstetric Risk Assessment Solutions Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Obstetric Risk Assessment Solutions Revenue (2021-2032)
- 10.2 China Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 10.2.1 China Obstetric Risk Assessment Solutions Revenue by Type (2021-2026)
- 10.2.2 China Obstetric Risk Assessment Solutions Revenue by Type (2027-2032)
- 10.3 China Obstetric Risk Assessment Solutions Revenue Share by Type (2021-2032)
- 10.4 China Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 10.4.1 China Obstetric Risk Assessment Solutions Revenue by Application (2021-2026)
- 10.4.2 China Obstetric Risk Assessment Solutions Revenue by Application (2027-2032)
- 10.5 China Obstetric Risk Assessment Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Obstetric Risk Assessment Solutions Revenue (2021-2032)
- 11.2 Asia Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 11.2.1 Asia Obstetric Risk Assessment Solutions Revenue by Type (2021-2026)
- 11.2.2 Asia Obstetric Risk Assessment Solutions Revenue by Type (2027-2032)
- 11.3 Asia Obstetric Risk Assessment Solutions Revenue Share by Type (2021-2032)
- 11.4 Asia Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 11.4.1 Asia Obstetric Risk Assessment Solutions Revenue by Application (2021-2026)
- 11.4.2 Asia Obstetric Risk Assessment Solutions Revenue by Application (2027-2032)
- 11.5 Asia Obstetric Risk Assessment Solutions Revenue Share by Application (2021-2032)
- 11.6 Asia Obstetric Risk Assessment Solutions Revenue by Country
- 11.6.1 Asia Obstetric Risk Assessment Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Obstetric Risk Assessment Solutions Revenue by Country (2021-2026)
- 11.6.3 Asia Obstetric Risk Assessment Solutions Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Obstetric Risk Assessment Solutions Revenue (2021-2032)
- 12.2 SAMEA Obstetric Risk Assessment Solutions Revenue by Type (2021-2032)
- 12.2.1 SAMEA Obstetric Risk Assessment Solutions Revenue by Type (2021-2026)
- 12.2.2 SAMEA Obstetric Risk Assessment Solutions Revenue by Type (2027-2032)
- 12.3 SAMEA Obstetric Risk Assessment Solutions Revenue Share by Type (2021-2032)
- 12.4 SAMEA Obstetric Risk Assessment Solutions Revenue by Application (2021-2032)
- 12.4.1 SAMEA Obstetric Risk Assessment Solutions Revenue by Application (2021-2026)
- 12.4.2 SAMEA Obstetric Risk Assessment Solutions Revenue by Application (2027-2032)
- 12.5 SAMEA Obstetric Risk Assessment Solutions Revenue Share by Application (2021-2032)
- 12.6 SAMEA Obstetric Risk Assessment Solutions Revenue by Country
- 12.6.1 SAMEA Obstetric Risk Assessment Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Obstetric Risk Assessment Solutions Revenue by Country (2021-2026)
- 12.6.3 SAMEA Obstetric Risk Assessment Solutions Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst